Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06576011 · ClinicalTrials.gov registry record · NA

2 College Truths and 1 Lie

A NA study, sponsored by Loyola Marymount University.

Completed
Registry status
NA
Development phase
392
Enrollment target

NCT06576011 is a NA study that has completed, run by Loyola Marymount University. The registered enrollment target is 392 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06576011, a NA study, has completed, sponsored by Loyola Marymount University.

COMPLETED
Registry status
NA
Development phase
392 participants
Enrollment target

Study Summary

This pilot randomized control trial (RCT) aims to assess the feasibility and efficacy of 2 College Truths \& 1 Lie (2T1L), a gamified social norms marketing campaign (SNMC) aimed at preventing and reducing first-year college student drinking. This program is designed to correct overestimations of peers' alcohol use behaviors, which, as shown in previous research, influence one's own future drinking behaviors. To examine the efficacy of 2T1L, this pilot trial will use a longitudinal design to determine whether playing 2T1L during the first few weeks of college will prevent increases in drinking or reduce subsequent alcohol use among first-year students during the same year, relative to exposure to a static social media-delivered SNMC or an assessment-only control condition. The investigators hypothesize that students randomized to receive the interactive 2T1L SNMC game will report less state psychological reactance in response to normative campus drinking statistics than students randomized to the non-gamified SNMC condition. Further, students in the 2T1L game condition will report greater accuracy in their perceptions of campus drinking norms and consume less alcohol following the six-week SNMC (short-term follow-up) and toward the end of the first year (long-term follow-up) compared to those randomized to both the active non-gamified SNMC and assessment-only control conditions.

Interventions

  • BEHAVIORAL Gamified Social Norms Marketing Campaign
  • BEHAVIORAL Social Norms Marketing Campaign

Trial Details

FieldValue
Enrollment Target 392 participants
Start Date 2024-08-05
Est. Completion 2025-05-15
Phase NA

Sponsor

Loyola Marymount University

7 total trials

What the Registry Record Tells You About NCT06576011

The ClinicalTrials.gov registry entry for NCT06576011 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 392 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Loyola Marymount University, which has 7 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Gamified Social Norms Marketing Campaign is the first listed.

NCT06576011 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT06576011 about?

NCT06576011 is a clinical study titled "2 College Truths and 1 Lie". This pilot randomized control trial (RCT) aims to assess the feasibility and efficacy of 2 College Truths \& 1 Lie (2T1L), a gamified social norms marketing campaign (SNMC) aimed at preventing and reducing first-year college student drinking. This program is designed to correct overestimations of pe...

What is the current status of trial NCT06576011?

This trial is currently completed. It is a NA study. The enrollment target is 392 participants. The study started on 2024-08-05. Estimated completion is 2025-05-15.

What interventions are being tested in trial NCT06576011?

The interventions under investigation include: Gamified Social Norms Marketing Campaign (BEHAVIORAL), Social Norms Marketing Campaign (BEHAVIORAL).

Who is sponsoring clinical trial NCT06576011?

This trial is sponsored by Loyola Marymount University, which has 7 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.